SCHEMBL4735306

SCHEMBL4735306

Fc1ccc(NCc2cnc(N3CCCCC3)s2)cc1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 6/20 0.47
▸ LMNA P02545 2/20 0.47
▸ TP53 P04637 1/20 0.45
▸ MAPT P10636 3/20 0.41
▸ ALDH1A1 P00352 4/20 0.41
▸ NPC1 O15118 4/20 0.40
▸ RAB9A P51151 3/20 0.40
▸ THRB P10828 1/20 0.40
▸ CACNA1B Q00975 2/20 0.40
▸ CACNA1H O95180 1/20 0.40
▸ MEN1 O00255 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ MLYCD O95822 1/20 0.38
▸ TSHR P16473 1/20 0.37
▸ CASP3 P42574 1/20 0.37
▸ SENP8 Q96LD8 1/20 0.37
▸ SENP7 Q9BQF6 1/20 0.37
▸ SENP6 Q9GZR1 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL3054021 0.99 SMN1; SMN2 (0.46) SMN1; SMN2LMNATP53MAPTALDH1A1
SCHEMBL3058601 0.99 LMNA (0.48) SMN1; SMN2LMNATP53MAPTALDH1A1
Hydrochloric Acid SCHEMBL3048350 0.97 LMNA (0.47) SMN1; SMN2LMNATP53MAPTALDH1A1
SCHEMBL4733920 0.87 LMNA (0.48) SMN1; SMN2LMNATP53MEN1KMT2A
SCHEMBL3053519 0.74 CACNA1B (0.47) SMN1; SMN2LMNAMAPTALDH1A1CACNA1B
SCHEMBL3053954 0.74 LMNA (0.44) SMN1; SMN2LMNATP53ALDH1A1NPC1
SCHEMBL15714866 0.74 ALDH1A1 (0.53) SMN1; SMN2LMNAMAPTALDH1A1NPC1
Hydrochloric Acid SCHEMBL4738978 0.73 CACNA1B (0.46) SMN1; SMN2LMNAMAPTALDH1A1CACNA1B
Hydrochloric Acid SCHEMBL3054076 0.73 LMNA (0.43) SMN1; SMN2LMNATP53ALDH1A1NPC1
Hydrochloric Acid SCHEMBL4739170 0.73 LMNA (0.43) SMN1; SMN2LMNATP53ALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008073461-A2 ION CHANNEL MODULATORS WYETH (US) 2008-06-19 — — WO claimed
US-20100267697-A1 ION CHANNEL MODULATORS WYETH (US) 2010-10-21 — — US disclosed
US-20100267697-A1 ION CHANNEL MODULATORS WYETH (US) 2010-10-21 — — US disclosed
WO-2008073936-A1 CARBOXAMIDE DERIVATIVES AS ION CHANNEL MODULATORS WYETH (US) 2008-06-19 — — WO disclosed
WO-2008073461-A2 ION CHANNEL MODULATORS WYETH (US) 2008-06-19 — — WO disclosed
WO-2008073461-A2 ION CHANNEL MODULATORS WYETH (US) 2008-06-19 — — WO disclosed
WO-2008073934-A1 ION CHANNEL MODULATORS WYETH (US) 2008-06-19 — — WO disclosed
WO-2008073929-A1 ION CHANNEL MODULATORS WYETH (US) 2008-06-19 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100267697-A1 ION CHANNEL MODULATORS CACNA1E, CACNA1A, CACNA1S SMN1; SMN2 1950/4885LMNA 2283/4885TP53 2391/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback